实用肝脏病杂志 ›› 2025, Vol. 28 ›› Issue (4): 529-532.doi: 10.3969/j.issn.1672-5069.2025.04.013

• 非酒精性脂肪性肝病 • 上一篇    下一篇

五脂胶囊联合复方甘草酸苷治疗非酒精性脂肪性肝炎患者疗效临床研究*

高倩, 陈璇, 周轶群, 杨欣, 康秀丽   

  1. 215000 江苏省苏州市中西医结合医院肝病科(高倩,周轶群);南京大学医学院附属苏州医院/苏州科技城医院中医科(陈璇,杨欣,康秀丽)
  • 收稿日期:2025-02-13 出版日期:2025-07-10 发布日期:2025-07-14
  • 通讯作者: 康秀丽,E-mail:kangxiuli1983@126.com
  • 作者简介:高倩,女,38岁,医学硕士,副主任中医师。E-mail:gq871006@163.com
  • 基金资助:
    *苏州市科技局中西医结合科研基金资助项目(编号:SKJYD2021214)

Clinical observation of Wuzhi capsule and compound glycyrrhizin combination in the treatment of patients with non-alcoholic steatohepatitis

Gao Qian, Chen Xuan, Zhou Yiqun, et al   

  1. Department of Liver Disease, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou 215000, Jiangsu Province, China
  • Received:2025-02-13 Online:2025-07-10 Published:2025-07-14

摘要: 目的 探讨五脂胶囊联合复方甘草酸苷治疗非酒精性脂肪性肝炎(NASH)患者的短期疗效。方法 2021年5月~2024年12月我院收治的120例NASH患者,被随机分为对照组60例和观察组60例,分别给予复方甘草酸苷注射液静脉滴注治疗或在此基础上加用五脂胶囊口服治疗8周。采用放射免疫法检测血清III型前胶原(PC-III)、层粘连蛋白(LN)、IV型胶原(IV-C)和透明质酸(HA)水平,采用化学发光法检测血清皮质醇(COR)、还原型谷胱甘肽(GSH)、超氧化物歧化酶(SOD)和丙二醛(MDA),采用ELISA法检测血清白介素-6(IL-6)、IL-1β和肿瘤坏死因子-α(TNF-α)。使用Fibrotouch行肝脏硬度检测(LSM)和受控衰减参数(CAP)检测。结果 在治疗8 w末,观察者血清ALT、AST和GGT水平分别为(38.9±2.7)U/L、(31.8±5.0)U/L和(46.7±3.8)U/L,均显著低于对照组【分别为(57.1±6.9)U/L、(43.7±6.9)U/L和(70.1±6.2)U/L,P<0.05】;观察组血清HA、PC-III和IV-C水平分别为(132.3±21.8)ng/mL、(85.2±17.0)mg/L和(34.6±5.0)μg/L,均显著低于对照组【分别为(181.9±20.6)ng/mL、(122.4±15.3)mg/L和(65.8±7.2)μg/L,P<0.05】;观察组血清COR和MDA水平分别为(231.7±23.6)nmol/L和(1.9±0.7)μmol/L,显著低于对照组【分别为(390.7±30.5)nmol/L和(5.0±1.2)μmol/L,P<0.05】,而血清GSH和SOD水平分别为(85.1±9.8)mg/L和(187.3±19.2)U/ml,均显著高于对照组【分别为(49.6±7.4)mg/L和(151.2±14.3)U/ml,P<0.05】;观察组CAP为(271.9±17.6)db/m,显著低于对照组【(287.2±25.1)db/m,P<0.05】,血清细胞因子水平也显著低于对照组(P<0.05)。结论 五酯胶囊联合复方甘草酸苷治疗NASH患者可获得较好的短期临床疗效,可能与减轻了机体氧化应激和细胞因子反应有关。

关键词: 非酒精性脂肪性肝炎, 五脂胶囊, 复方甘草酸苷, 氧化应激, 治疗

Abstract: Objective The aim of this study was to investigate short-term efficacy of Wuzhi capsule, a herbal medicine compound, and compound glycyrrhizin combination in the treatment of patients with non-alcoholic steatohepatitis(NASH). Methods 120 patients with NASH were encountered in our hospital between May 2021 and December 2024, and were randomly assigned to receive compound glycyrrhizin intravenously in 60 cases in the control or to receive oral herbal medicine plus compound glycyrrhizin in another 60 cases in the observation for 8 weeks. Serum procollagen-III (PC-III),laminin (LN),collage type Ⅳ(IV-C) and hyaluronidase (HA) levels were detected by RIA; serum(cortisol(COR),glutathione (GSH),superoxide dismutase(SOD) and malondialdehyde (MDA) levels were assayed by chemiluminescence; Serum interleukin-6 (IL-6),IL-1βand tumor necrosis factor-α(TNF-α) levels were determined by ELISA. Liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) were determinedby Fibrotouch. Results By end of eight week treatment, serum alanine aminotransferase,aspartate aminotransferase and γ-glutamyl transpeptidase levels in the observation group were (38.9±2.7)U/L, (31.8±5.0)U/L and (46.7±3.8)U/L, all significantly lower than [(57.1±6.9)U/L, (43.7±6.9)U/L and (70.1±6.2)U/L, respectively, P<0.05] in the control; serum HA, PC-III and IV-C levels were (132.3±21.8)ng/mL, (85.2±17.0)mg/L and (34.6±5.0)μg/L, all significantly lower than [(181.9±20.6)ng/mL, (122.4±15.3)mg/L and (65.8±7.2)μg/L, respectively, P<0.05] in the control group; serum COR and MDA levels were (231.7±23.6)nmol/L and (1.9±0.7)μmol/L, both much lower than [(390.7±30.5)nmol/L and (5.0±1.2)μmol/L, respectively, P<0.05], while serum GSH and SOD levels were (85.1±9.8)mg/L and (187.3±19.2)U/ml, both much higher than [(49.6±7.4)mg/L and (151.2±14.3)U/ml, respectively, P<0.05] in the control; CAP was (271.9±17.6)db/m, much lower than [(287.2±25.1)db/m, P<0.05], and serum cytokine levels were also much lower than in the control group (P<0.05). Conclusion Combiantion ofWuzhi capsule and compound glycyrrhizin in treatment of patients with NASH is short-termly efficacious, which might relieve oxidative stress and cytokine reactions.

Key words: Non-alcoholic steatohepatitis, Wuzhi capsule,a herbal medicine compound, Compound glycyrrhizin, Therapy